Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015 (2015), Article ID 943659, 8 pages
http://dx.doi.org/10.1155/2015/943659
Research Article

MicroRNA-223 Expression Is Upregulated in Insulin Resistant Human Adipose Tissue

1Department of Obstetrics/Gynecology, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USA
2Department of Biostatistics, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USA
3Department of Surgery, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USA
4Section of Reproductive Endocrinology, Infertility & Genetics, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USA
5Institute of Molecular Medicine and Genetics, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USA
6Neuroscience Program, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USA
7Department of Medicine, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USA

Received 5 November 2014; Revised 26 March 2015; Accepted 26 March 2015

Academic Editor: Joseph Fomusi Ndisang

Copyright © 2015 Tung-Yueh Chuang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Malumbres, “MiRNAs and cancer: an epigenetics view,” Molecular Aspects of Medicine, vol. 34, no. 4, pp. 863–874, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Müller, M. Schneider, G. Biemer-Daub, and S. Wied, “Microvesicles released from rat adipocytes and harboring glycosylphosphatidylinositol-anchored proteins transfer RNA stimulating lipid synthesis,” Cellular Signalling, vol. 23, no. 7, pp. 1207–1223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Zhu, S.-C. Ng, A. V. Segr et al., “The Lin28/let-7 axis regulates glucose metabolism,” Cell, vol. 147, no. 1, pp. 81–94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Esau, S. Davis, S. F. Murray et al., “miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting,” Cell Metabolism, vol. 3, no. 2, pp. 87–98, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. He, L. Zhu, N. Gupta, Y. Chang, and F. Fang, “Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes,” Molecular Endocrinology, vol. 21, no. 11, pp. 2785–2794, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. N. Poy, L. Eliasson, J. Krutzfeldt et al., “A pancreatic islet-specific microRNA regulates insulin secretion,” Nature, vol. 432, no. 7014, pp. 226–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. B. M. Herrera, H. E. Lockstone, J. M. Taylor et al., “Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes,” Diabetologia, vol. 53, no. 6, pp. 1099–1109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Y. Ling, H. S. Ou, S. D. Feng et al., “Changes in microRNA (miR) profile and effects of miR-320 in insulin-resistant 3t3-l1 adipocytes,” Clinical and Experimental Pharmacology and Physiology, vol. 36, no. 9, pp. e32–e39, 2009. View at Publisher · View at Google Scholar
  9. R. Azziz, E. Carmina, D. Dewailly et al., “The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report,” Fertility and Sterility, vol. 91, no. 2, pp. 456–488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. T. P. Ciaraldi, V. Aroda, S. Mudaliar, R. J. Chang, and R. R. Henry, “Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 157–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. H. Chen, S. Heneidi, J. M. Lee et al., “miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance,” Diabetes, vol. 62, no. 7, pp. 2278–2286, 2013. View at Publisher · View at Google Scholar
  12. H. Lu, R. J. Buchan, and S. A. Cook, “MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism,” Cardiovascular Research, vol. 86, no. 3, pp. 410–420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Azziz, K. S. Woods, R. Reyna, T. J. Key, E. S. Knochenhauer, and B. O. Yildiz, “The prevalence and features of the polycystic ovary syndrome in an unselected population,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2745–2749, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Azziz, W. Y. Chang, F. Z. Stanczyk, and K. Woods, “Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 99, no. 2, pp. 599–604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Azziz, “Fat biopsy procedure with Dr. Ricardo Azziz,” in Mcgwebcontent, Georgia Health Sciences University, Augusta, Ga, USA, 2012, http://www.youtube.com/. View at Google Scholar
  16. M. J. Neville, J. M. Collins, A. L. Gloyn, M. I. McCarthy, and F. Karpe, “Comprehensive human adipose tissue mRNA and microRNA endogenous control selection for quantitative real-time-PCR normalization,” Obesity, vol. 19, no. 4, pp. 888–892, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. H. Chen, S. Heneidi, J. M. Lee et al., “miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of Polycystic Ovary Syndrome patients and women with insulin resistance,” Diabetes, vol. 62, no. 7, pp. 2278–2286, 2013. View at Publisher · View at Google Scholar
  18. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar
  19. H. Ruan and H. F. Lodish, “Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha,” Cytokine and Growth Factor Reviews, vol. 14, no. 5, pp. 447–455, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. P. R. Shepherd and B. B. Kahn, “Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus,” The New England Journal of Medicine, vol. 341, no. 4, pp. 248–257, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Thomson, M. G. Williams, and S. C. Frost, “Development of insulin resistance in 3T3-L1 adipocytes,” The Journal of Biological Chemistry, vol. 272, no. 12, pp. 7759–7764, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. E. D. Abel, O. Peroni, J. K. Kim et al., “Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver,” Nature, vol. 409, no. 6821, pp. 729–733, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Tozzo, P. R. Shepherd, L. Gnudi, and B. B. Kahn, “Transgenic GLUT-4 overexpression in fat enhances glucose metabolism: preferential effect on fatty acid synthesis,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 268, no. 5, pp. E956–E964, 1995. View at Google Scholar · View at Scopus
  24. Y. Xu, H. Jin, X. Yang et al., “MicroRNA-93 inhibits inflammatory cytokine production in LPS-stimulated murine macrophages by targeting IRAK4,” FEBS Letters, vol. 588, no. 9, pp. 1692–1698, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Zhuang, C. Meng, X. Guo et al., “A novel regulator of macrophage activation: MiR-223 in obesity-associated adipose tissue inflammation,” Circulation, vol. 125, no. 23, pp. 2892–2903, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Olefsky and C. K. Glass, “Macrophages, inflammation, and insulin resistance,” Annual Review of Physiology, vol. 72, pp. 219–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. A. Pulikkan, V. Dengler, P. S. Peramangalam et al., “Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia,” Blood, vol. 115, no. 9, pp. 1768–1778, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Petrocca, R. Visone, M. R. Onelli et al., “E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer,” Cancer Cell, vol. 13, no. 3, pp. 272–286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Haneklaus, M. Gerlic, L. A. J. O'Neill, and S. L. Masters, “MiR-223: infection, inflammation and cancer,” Journal of Internal Medicine, vol. 274, no. 3, pp. 215–226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. E. M. Pinatel, F. Orso, E. Penna et al., “miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions,” PLoS ONE, vol. 9, no. 1, Article ID e84859, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Li, Z. Li, F. Guo et al., “MiR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma,” Journal of Biomedical Science, vol. 18, no. 1, article 24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Li, Y. Guo, X. Liang et al., “MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4,” Journal of Cancer Research and Clinical Oncology, vol. 138, no. 5, pp. 763–774, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Wei, J. Yang, L. Yi et al., “MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer,” Scientific Reports, vol. 4, article 7546, 2014. View at Publisher · View at Google Scholar
  34. L. Du, J. J. Schageman, M. C. Subauste et al., “miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1,” Molecular Cancer Research, vol. 7, no. 8, pp. 1234–1243, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Chen, S. Chen, Y. L. Xiu, K. X. Sun, Z. H. Zong, and Y. Zhao, “RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression,” Molecular Cancer, vol. 14, article 31, 2015. View at Publisher · View at Google Scholar
  36. K. Ohta, H. Hoshino, J. Wang et al., “MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A,” Oncotarget, vol. 6, no. 5, pp. 3211–3224, 2015. View at Google Scholar
  37. X. Lyu, W. Fang, L. Cai et al., “TGFbetaR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness,” Molecular Cancer, vol. 13, no. 1, article 51, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Singh, A. M. Ronghe, A. Chatterjee, N. K. Bhat, and H. K. Bhat, “MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis,” Carcinogenesis, vol. 34, no. 5, pp. 1165–1172, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Long, Y. Wang, W. Wang, B. H. J. Chang, and F. R. Danesh, “Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions,” The Journal of Biological Chemistry, vol. 285, no. 30, pp. 23457–23465, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Shi, B. Fisslthaler, N. Zippel et al., “MicroRNA-223 antagonizes angiogenesis by targeting beta1 integrin and preventing growth factor signaling in endothelial cells,” Circulation Research, vol. 113, no. 12, pp. 1320–1330, 2013. View at Publisher · View at Google Scholar · View at Scopus